GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Interest Expense

Krebs Biochemicals & Industries (BOM:524518) Interest Expense : ₹-46.9 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Krebs Biochemicals & Industries's interest expense for the three months ended in Mar. 2024 was ₹ -12.7 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-46.9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Krebs Biochemicals & Industries's Operating Income for the three months ended in Mar. 2024 was ₹ -47.9 Mil. Krebs Biochemicals & Industries's Interest Expense for the three months ended in Mar. 2024 was ₹ -12.7 Mil. Krebs Biochemicals & Industries did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Krebs Biochemicals & Industries Interest Expense Historical Data

The historical data trend for Krebs Biochemicals & Industries's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries Interest Expense Chart

Krebs Biochemicals & Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -59.28 -62.72 -53.85 -29.73 -46.89

Krebs Biochemicals & Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.29 -10.97 -11.34 -11.86 -12.72

Krebs Biochemicals & Industries Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-46.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krebs Biochemicals & Industries  (BOM:524518) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Krebs Biochemicals & Industries's Interest Expense for the three months ended in Mar. 2024 was ₹-12.7 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹-47.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹1,835.0 Mil.

Krebs Biochemicals & Industries's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Krebs Biochemicals & Industries did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Krebs Biochemicals & Industries (BOM:524518) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Interest Expense
Comparable Companies
BOM:532878 BOM:531173 NSE:VAISHALI BOM:537536 BOM:524824 BOM:532637 NSE:SOTAC BOM:540702 BOM:532384 BOM:531569 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
KREBSBIO:India
Address
Road No. 8, Banjara Hills, 8-2-577/B, Plot No. 34, 3rd Floor, Maas Heights, Hyderabad, TG, IND, 500 034
Website
http://www.krebsbiochem.com
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries (BOM:524518) Headlines

No Headlines